Shift in Treatment Patterns
Insulair® - Proven pMDI Effectiveness
Recently, more new and proven drugs are being prepared and formulated for use in a pressurized metered dose inhaler (pMDI). There is an increasing demand for a convenient pMDI inhaler solution for the treatment of Diabetics with insulin and for new Bio-tech drugs. This shift in treatment patterns is largely due to the technological maturing of the pMDI inhaler to administer systemic drugs through the lungs. Secondly, that the majority of patients prefer to use inhalers over other methods of drug delivery such as injection1.
Click here to read more on our cost effective solution
1 Diabetes Care 24:1556-1559, 2001: "Treatment Satisfaction With Inhaled Insulin in Patients With Type 1 Diabetes, A randomized controlled trial." Robert A. Gerber, PHARMD, MA1, Joseph C. Cappelleri, PHD, MPH1, Ione A. Kourides, MD2 and Robert A. Gelfand, MD1